Welgus H G, Bauer E A, Stricklin G P
J Invest Dermatol. 1986 Nov;87(5):592-6. doi: 10.1111/1523-1747.ep12455837.
Blister fluids from a variety of bullous disorders were examined for the presence of human collagenase inhibitor. A protein immunologically identical to the collagenase inhibitor produced by human skin fibroblasts was found in high concentrations within bullae of diverse etiologies. Levels of collagenase inhibitor in blister fluids ranged from 0.9-12.5 micrograms/ml, averaging 4.9 micrograms/ml. The mean values were 3- to 4-fold greater than those present in the sera of corresponding patients and exceeded plasma levels by 6- to 8-fold. The time course of collagenase inhibitor accumulation in blister fluid was studied using heat- and suction-induced bullae. The concentration in newly formed blisters was approximately 0.5 micrograms/ml, virtually identical to plasma inhibitor levels, and remained constant for approximately 4 h. Inhibitor concentrations then rose rapidly, reaching peak values of approximately 6 micrograms/ml after 48 h. We speculate that the role of this inhibitor in blister fluid involves the inhibitions of active proteinases within the bulla cavity and may occur to limit the extent of blister formation or to assist in wound repair.
对多种大疱性疾病的水疱液进行检测,以确定其中是否存在人胶原酶抑制剂。在不同病因引起的水疱中发现了一种在免疫学上与人皮肤成纤维细胞产生的胶原酶抑制剂相同的蛋白质,且浓度很高。水疱液中胶原酶抑制剂的水平在0.9 - 12.5微克/毫升之间,平均为4.9微克/毫升。其平均值比相应患者血清中的水平高3至4倍,比血浆水平高6至8倍。利用热诱导和抽吸诱导的水疱研究了胶原酶抑制剂在水疱液中积累的时间过程。新形成的水疱中抑制剂浓度约为0.5微克/毫升,与血浆抑制剂水平几乎相同,并在约4小时内保持恒定。随后抑制剂浓度迅速上升,48小时后达到约6微克/毫升的峰值。我们推测,这种抑制剂在水疱液中的作用涉及对水疱腔内活性蛋白酶的抑制,可能是为了限制水疱形成的程度或协助伤口修复。